PCSA

Processa Pharmaceuticals, Inc.
NasdaqCMUSDEQUITY Healthcare DELAYED
Last price
2.04
▼ 0.10 (4.90%)
MARKET ·

Price

Open
2.14
Prev close
2.15
Day high
2.21
Day low
2.00
Volume
72.72K
Market cap
$5.81M
P/E (TTM)
3.20
52W range
1.67 – 14.25

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-14.40% -13.0%
1M
-27.53% -31.3%
3M
-18.91% -22.0%
6M
-0.95% -12.0%
YTD
-27.78% -40.1%
1Y
-59.81% -79.8%
3Y
-98.93% -173.1%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$5.81M
Enterprise value$5.61M
Revenue (TTM)
Gross profit
EBITDA$-12.86M
Net income$-13.44M
EPS (TTM)$0.65
Free cash flow$-8.50M
Total cash$196.32K
Total debt$0
Book value / share$0.95
Shares outstanding2.79M
Float2.68M
Short % of float7.30%
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E3.20
Forward P/E-0.55
PEG ratio
Price / sales
Price / book2.19
EV / revenue
EV / EBITDA-0.44
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-464.20%
Return on assets-156.78%
Debt / equity
Current ratio0.87
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2024202320222021
Total revenue$0$0$0$0
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$11.85M-$11.12M-$27.42M-$11.43M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Sep 2025 -2.00-1.75 +12.5%
Jun 2025 -5.75-6.25 -8.7%
Mar 2025 -19.25-7.50 +61.0%
Dec 2024 -23.00-18.50 +19.6%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders14.82%
Held by institutions18.70%
Institutions holding14
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
414.06K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 7, 26
NG GEORGE K
Chief Executive Officer
1.60K Direct
Jul 1, 26
NG GEORGE K
Chief Executive Officer
BUY 3.06K $5.90K Direct
Jun 30, 26
SKIBSTED RUSSELL L
Chief Financial Officer
BUY 3.28K $6.33K Direct
Jun 30, 26
YOUNG DAVID
Officer and Director
BUY 2.53K $4.88K Direct
Jun 30, 26
LIN PATRICK
Officer
BUY 2.11K $4.07K Direct
Jun 30, 26
GUY WENDY
Officer
BUY 2.44K $4.70K Direct
Jun 26, 26
NEAL JAMES R
Director
203 Direct
Jun 26, 26
YORKE JUSTIN W
Director
203 Direct
Jun 26, 26
BALUCH KHOSO
Director
203 Direct
Jun 26, 26
PANNU GERALDINE
Director
203 Direct
Jun 15, 26
SKIBSTED RUSSELL L
Chief Financial Officer
BUY 2.65K $5.89K Direct
Jun 15, 26
YOUNG DAVID
Officer and Director
BUY 2.07K $4.59K Direct
Jun 15, 26
NG GEORGE K
Chief Executive Officer
BUY 2.46K $5.47K Direct
Jun 15, 26
LIN PATRICK
Officer
BUY 1.83K $4.07K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BALUCH KHOSO
Director 2.53K Conversion of Exercise of derivative security
BIGORA SIAN
Officer 7.75K Purchase
GUY WENDY
Officer 14.73K Purchase
LIN PATRICK
Officer 14.85K Purchase
NEAL JAMES R
Director 1.02K Conversion of Exercise of derivative security
NG GEORGE K
Chief Executive Officer 19.78K Purchase
PANNU GERALDINE
Director 2.39K Conversion of Exercise of derivative security
SKIBSTED RUSSELL L
Chief Financial Officer 16.69K Purchase
YORKE JUSTIN W
Director 2.10K Conversion of Exercise of derivative security
YOUNG DAVID
Officer and Director 24.41K Purchase

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
2.33
-12.58% from price
SMA 20
2.33
-10.55% from price
SMA 50
2.22
-6.43% from price
SMA 100
2.47
-17.56% from price
SMA 200
3.29
-36.68% from price
EMA 12
2.26
-9.61% from price
EMA 26
2.29
-11.02% from price
EMA 50
2.33
-12.29% from price
RSI (14)
43.0
Neutral
MACD (12,26,9)
-0.04
Hist -0.04
ATR (14)
0.18
8.89% of price
Realised vol 30D
157.5%
Annualised
Bollinger upper
2.86
20, 2σ
Bollinger lower
1.79
20, 2σ
50 / 200 cross
Death
2.22 vs 3.29
Trend bias
Below 200
-36.68%

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.47
More volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
157.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-84.6%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.18
8.89% of price
Beta (reported)
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 2.04
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.